Rafferty Asset Management, LLC Emergent Bio Solutions Inc. Transaction History

Rafferty Asset Management, LLC

$22.9 Billion
Q1 2025

A detailed history of Rafferty Asset Management, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 111,100 shares of EBS stock, worth $721,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,100

Previous 144,720 23.23%

Holding current value

$721,039

Previous $1.38 Million 61.03%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$4.66 - $11.66 $156,669 - $392,009	-33,620 Reduced 23.23%	111,100 $539,000
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $5,396 - $8,367	699 Added 0.49%	144,720 $1.38 Million
Q3 2024 Nov 13, 2024	BUY	$5.72 - $14.77 $823,800 - $2.13 Million	144,021 New	144,021 $1.2 Million
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.21 $1.46 Million - $2.62 Million	198,538 Added 51.83%	581,625 $4.27 Million
Q1 2023 May 11, 2023	SELL	$7.79 - $16.29 $253,213 - $529,506	-32,505 Reduced 7.82%	383,087 $3.97 Million
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $1.99 Million - $3.87 Million	180,609 Added 76.86%	415,592 $4.91 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $2.15 Million - $3.84 Million	107,256 Added 83.97%	234,983 $4.93 Million
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $518,265 - $824,650	-18,901 Reduced 12.89%	127,727 $3.97 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $545,850 - $781,367	14,963 Added 11.36%	146,628 $6.02 Million
Q4 2021 Feb 10, 2022	BUY	$33.11 - $55.01 $2.55 Million - $4.24 Million	77,075 Added 141.19%	131,665 $5.72 Million
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $676,946 - $892,996	13,520 Added 32.92%	54,590 $2.73 Million
Q2 2021 Aug 10, 2021	BUY	$56.61 - $80.46 $233,459 - $331,817	4,124 Added 11.16%	41,070 $2.59 Million
Q1 2021 May 10, 2021	BUY	$86.23 - $125.19 $2.23 Million - $3.23 Million	25,807 Added 231.68%	36,946 $3.43 Million
Q4 2020 Feb 10, 2021	SELL	$79.17 - $111.47 $719,813 - $1.01 Million	-9,092 Reduced 44.94%	11,139 $998,000
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $307,490 - $506,564	3,754 Added 22.78%	20,231 $2.09 Million
Q2 2020 Aug 07, 2020	BUY	$54.33 - $89.52 $642,180 - $1.06 Million	11,820 Added 253.81%	16,477 $1.3 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $1.72 Million - $2.4 Million	-34,943 Reduced 88.24%	4,657 $269,000
Q4 2019 Feb 10, 2020	SELL	$51.21 - $59.06 $766,255 - $883,714	-14,963 Reduced 27.42%	39,600 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $2.1 Million - $2.96 Million	-51,835 Reduced 48.72%	54,563 $2.85 Million
Q2 2019 Aug 09, 2019	BUY	$39.92 - $53.86 $1.08 Million - $1.45 Million	26,947 Added 33.92%	106,398 $5.14 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $3.83 Million - $5.26 Million	79,451 New	79,451 $4.01 Million

Others Institutions Holding EBS

# of Institutions

177

Shares Held

38.3M

Call Options Held

94.1K

Put Options Held

153K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $324M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Emergent Bio Solutions Inc. Transaction History